AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2019 Issue 4; Section X - New Technology
New Therapeutic Substances
Eleven new substance values were added to code table XW0, Anatomical Regions, Introduction, as noted below. Device/Substance/TechnologyJ Apalutamide Antineoplastic K Fosfomycin Anti-infective L Erdafitinib Antineoplastic N Meropenem-vaborbactam Anti-infective Q Tagraxofusp-erzs Antineoplastic R Venetoclax Antineoplastic S Iobenguane I-131Antineoplastic T Ruxolitinib U Imipenem-cilastatin-relebactam Anti-infective V Gilteritinib Antineoplastic W Caplacizumab Apalutamide Antineoplastic Apalutamide, also known by its trade name ERLEADA™, is an oral androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (NM-CRPC). Prostate cancer that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone...
To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .
Thank you for choosing Find-A-Code, please Sign In to remove ads.